|
Volumn 57, Issue 3, 2010, Pages 89-95
|
The role of pelvic MRI in assesment of combined surgical and infliximab treatment for perianal Crohn's disease.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
ABSCESS;
ADULT;
ARTICLE;
CROHN DISEASE;
FEMALE;
HUMAN;
MALE;
MULTIMODALITY CANCER THERAPY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PELVIS;
RECTUM FISTULA;
ABSCESS;
ADULT;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
COMBINED MODALITY THERAPY;
CROHN DISEASE;
FEMALE;
HUMANS;
MAGNETIC RESONANCE IMAGING;
MALE;
PELVIS;
RECTAL FISTULA;
|
EID: 79952114915
PISSN: 0354950X
EISSN: None
Source Type: Journal
DOI: 10.2298/ACI1003089G Document Type: Article |
Times cited : (8)
|
References (0)
|